Evidence map›Paper›PMID 22371879›Full record

ArticleBlood2012

Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists.

Paul D Baum, Jennifer J Young, Diane Schmidt, Qianjun Zhang, Rebecca Hoh, Michael Busch, Jeffrey Martin, Steven Deeks, Joseph M McCune

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Systemic immunity in cancer.Nature reviews. Cancer · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Harnessing CD8Frontiers in immunology · 2019
    Review
  17. Article
  18. Immunotherapy in People With HIV and Cancer.Frontiers in immunology · 2019
    Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Paul D BaumDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143-1234, USA. paul.baum@ucsf.edu
Jennifer J Young
Diane Schmidt
Qianjun Zhang
Rebecca Hoh
Michael Busch
Jeffrey Martin
Steven Deeks
Joseph M McCune
University of California, San Francisco · USBlood Systems Research Institute · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LANDAY, ALAN L · 2008 to 2012
$10.9M
HIV EFFECTS ON THE CENTRAL HEMATOLYMPHOID SYSTEMR37AI040312 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2000 to 2010
$5.0M
NIH Director's Pioneer Award (RMI)DP1OD000329 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2004 to 2008
$4.2M
Thymic Function in Adults With HIV-1 DiseaseU01AI043864 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2003 to 2007
$3.0M
The impact of early antiretroviral therapy on HIV persistence and inflammationR01AI087145 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2009 to 2010
$1.6M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
Impact of HIV on the T cell repertoireK23AI073100 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BAUM, PAUL D · 2007 to 2011
$718k
NCRR NIH HHS UL1 RR024131NIAID NIH HHS AI 76174NIAID NIH HHS K23 AI 073100NIAID NIH HHS K23 AI073100NIAID NIH HHS K24 AI069994NIAID NIH HHS K24AI069994NIAID NIH HHS P01 AI076174NIAID NIH HHS P0 AI27763NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI087145NIAID NIH HHS R24 AI067039NIAID NIH HHS R37 AI040312NIAID NIH HHS R37 AI40312NIAID NIH HHS U01 AI043864NIAID NIH HHS UO1 AI43864,NIH HHS DP1 OD000329NIH HHS DPI OD00329
6 · The paper itself

Abstract

HIV infection results in a decrease in circulating CD4(+) T-cell and naive T-cell numbers. If such losses were associated with an erosion of T-cell receptor (TCR) repertoire diversity in the peripheral T-cell pool, this might exacerbate the state of persistent immunodeficiency. Existing methods for the analysis of the TCR repertoire have demonstrated skewed distributions of TCR genes in HIV-infected subjects but cannot directly measure TCR diversity. Here we used AmpliCot, a quantitative assay based on DNA hybridization kinetics, to measure TCR diversity in a cross-sectional comparison of 19 HIV-infected persons to 18 HIV-uninfected controls. HIV-infected persons had a 10-fold decrease in total TCR repertoire diversity in 1.5 mL of blood compared with uninfected controls, with decreased diversity correlating most closely with a lower CD4(+) T-cell percentage. Nonetheless, the TCR repertoire diversity of sort-purified T-cell subpopulations in HIV-infected and HIV-uninfected subjects was comparable. These observations suggest that the TCR repertoire diversity changes in whole blood during HIV disease progression are primarily the result of changes in the number and proportion of T-cell subpopulations and that most HIV-infected persons may retain a sufficiently diverse TCR repertoire to permit immune reconstitution with antiretroviral therapy alone, without thymopoiesis.

Indexed as

AdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCohort StudiesDisease ProgressionDown-RegulationFemaleFollow-Up StudiesGene Rearrangement, T-LymphocyteGenetic VariationHIV-1HIV InfectionsHumansMaleMiddle AgedReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID22371879
PMCPMC3325037
OpenAlexW2148295649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.